Smith R, Gøtzsche PC, Groves T. Should journals stop publishing research funded by the drug industry? BMJ 2014;348:g171
(doi: 10.1136/bmj.g171)
The BMJ and its sibling journals have stopped publishing research funded by the tobacco industry for two main reasons: the research is corrupted and the companies publish their research to advance their commercial aims, oblivious of the harm they do. Two authors of this article say that research funded by the drug industry is also flawed and published to encourage sales, but the third author says that the industries are fundamentally different and that moves are afoot to increase integrity. The BMJ considers drug and devices trials only if the authors also commit to making the relevant anonymised patient level data available on reasonable request.
http://www.bmj.com/content/348/bmj.g171
(doi: 10.1136/bmj.g171)
The BMJ and its sibling journals have stopped publishing research funded by the tobacco industry for two main reasons: the research is corrupted and the companies publish their research to advance their commercial aims, oblivious of the harm they do. Two authors of this article say that research funded by the drug industry is also flawed and published to encourage sales, but the third author says that the industries are fundamentally different and that moves are afoot to increase integrity. The BMJ considers drug and devices trials only if the authors also commit to making the relevant anonymised patient level data available on reasonable request.
http://www.bmj.com/content/348/bmj.g171
Comments